喵ID:krTWjG免责声明

Immune profiles to distinguish hospitalized versus ambulatory COVID-19 cases in older patients.

基本信息

DOI:
10.1016/j.isci.2022.105608
发表时间:
2022-12-22
期刊:
影响因子:
5.8
通讯作者:
Hioe, Catarina E.
中科院分区:
综合性期刊2区
文献类型:
Journal Article
作者: Klingler, Jeromine;Lambert, Gregory S.;Bandres, Juan C.;Emami-Gorizi, Rozita;Nadas, Arthur;Oguntuyo, Kasopefoluwa Y.;Amanat, Fatima;Bermudez-Gonzalez, Maria C.;Gleason, Charles;Kleiner, Giulio;Simon, Viviana;Lee, Benhur;Zolla-Pazner, Susan;Upadhyay, Chitra;Hioe, Catarina E.研究方向: Science & Technology - Other TopicsMeSH主题词: --
关键词: --
来源链接:pubmed详情页地址

文献摘要

A fraction of patients with COVID-19 develops severe disease requiring hospitalization, while the majority, including high-risk individuals, experience mild symptoms. Severe disease has been associated with higher levels of antibodies and inflammatory cytokines but often among patients with diverse demographics and comorbidity status. This study evaluated hospitalized vs. ambulatory patients with COVID-19 with demographic risk factors for severe COVID-19: median age of 63, >80% male, and >85% black and/or Hispanic. Sera were collected four to 243 days after symptom onset and evaluated for binding and functional antibodies as well as 48 cytokines and chemokines. SARS-CoV-2-specific antibody levels and functions were similar in ambulatory and hospitalized patients. However, a strong correlation between anti-S2 antibody levels and the other antibody parameters, along with higher IL-27 levels, was observed in hospitalized but not ambulatory cases. These data indicate that antibodies against the relatively conserved S2 spike subunit and immunoregulatory cytokines such as IL-27 are potential immune determinants of COVID-19. Comparable SARS-CoV-2 Ab profiles of hospitalized and ambulatory cases Concordance of Ab responses to spike S2 vs. S1 subunits only in hospitalized cases High levels of serum IL-27 after convalescence in hospitalized patients Health sciences; Population; Immunology; Immune response
一部分新冠病毒(COVID - 19)患者会发展为需要住院治疗的重症,而包括高危个体在内的大多数患者则症状较轻。重症与较高水平的抗体和炎性细胞因子有关,但通常出现在不同人口统计学特征和合并症状况的患者中。 本研究评估了具有新冠重症人口统计学风险因素的住院患者和非住院患者:中位年龄为63岁,男性占80%以上,黑人和/或西班牙裔占85%以上。在症状出现后4到243天收集血清,并对结合抗体和功能性抗体以及48种细胞因子和趋化因子进行评估。 在非住院患者和住院患者中,新冠病毒特异性抗体水平和功能相似。然而,在住院患者(而非非住院患者)中观察到抗S2抗体水平与其他抗体参数之间存在强相关性,同时白细胞介素 - 27(IL - 27)水平较高。这些数据表明,针对相对保守的S2刺突亚单位的抗体以及诸如IL - 27等免疫调节细胞因子是新冠病毒的潜在免疫决定因素。 住院患者和非住院患者具有相似的新冠病毒抗体谱 仅在住院患者中刺突S2与S1亚单位抗体反应的一致性 住院患者康复后血清IL - 27水平较高 健康科学;人群;免疫学;免疫反应
参考文献(82)
被引文献(3)
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.
DOI:
10.15585/mmwr.mm6915e3
发表时间:
2020-04-17
期刊:
MMWR. Morbidity and mortality weekly report
影响因子:
0
作者:
Garg S;Kim L;Whitaker M;O'Halloran A;Cummings C;Holstein R;Prill M;Chai SJ;Kirley PD;Alden NB;Kawasaki B;Yousey-Hindes K;Niccolai L;Anderson EJ;Openo KP;Weigel A;Monroe ML;Ryan P;Henderson J;Kim S;Como-Sabetti K;Lynfield R;Sosin D;Torres S;Muse A;Bennett NM;Billing L;Sutton M;West N;Schaffner W;Talbot HK;Aquino C;George A;Budd A;Brammer L;Langley G;Hall AJ;Fry A
通讯作者:
Fry A
An inflammatory cytokine signature predicts COVID-19 severity and survival.
DOI:
10.1038/s41591-020-1051-9
发表时间:
2020-10
期刊:
Nature medicine
影响因子:
82.9
作者:
Del Valle DM;Kim-Schulze S;Huang HH;Beckmann ND;Nirenberg S;Wang B;Lavin Y;Swartz TH;Madduri D;Stock A;Marron TU;Xie H;Patel M;Tuballes K;Van Oekelen O;Rahman A;Kovatch P;Aberg JA;Schadt E;Jagannath S;Mazumdar M;Charney AW;Firpo-Betancourt A;Mendu DR;Jhang J;Reich D;Sigel K;Cordon-Cardo C;Feldmann M;Parekh S;Merad M;Gnjatic S
通讯作者:
Gnjatic S
A serological assay to detect SARS-CoV-2 seroconversion in humans.
DOI:
10.1038/s41591-020-0913-5
发表时间:
2020-07
期刊:
Nature medicine
影响因子:
82.9
作者:
Amanat F;Stadlbauer D;Strohmeier S;Nguyen THO;Chromikova V;McMahon M;Jiang K;Arunkumar GA;Jurczyszak D;Polanco J;Bermudez-Gonzalez M;Kleiner G;Aydillo T;Miorin L;Fierer DS;Lugo LA;Kojic EM;Stoever J;Liu STH;Cunningham-Rundles C;Felgner PL;Moran T;García-Sastre A;Caplivski D;Cheng AC;Kedzierska K;Vapalahti O;Hepojoki JM;Simon V;Krammer F
通讯作者:
Krammer F
The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity
DOI:
10.4049/jimmunol.173.9.5626
发表时间:
2004-11-01
期刊:
JOURNAL OF IMMUNOLOGY
影响因子:
4.4
作者:
Artis, D;Villarino, A;Hunter, CA
通讯作者:
Hunter, CA
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans.
DOI:
10.1126/science.abc6261
发表时间:
2020-09-04
期刊:
Science (New York, N.Y.)
影响因子:
0
作者:
Arunachalam PS;Wimmers F;Mok CKP;Perera RAPM;Scott M;Hagan T;Sigal N;Feng Y;Bristow L;Tak-Yin Tsang O;Wagh D;Coller J;Pellegrini KL;Kazmin D;Alaaeddine G;Leung WS;Chan JMC;Chik TSH;Choi CYC;Huerta C;Paine McCullough M;Lv H;Anderson E;Edupuganti S;Upadhyay AA;Bosinger SE;Maecker HT;Khatri P;Rouphael N;Peiris M;Pulendran B
通讯作者:
Pulendran B

数据更新时间:{{ references.updateTime }}

关联基金

Harnessing Abs specific for immunogenic and conserved Env epitopes to protect against HIV
批准号:
10401312
批准年份:
2018
资助金额:
81.34
项目类别:
Hioe, Catarina E.
通讯地址:
Icahn Sch Med Mt Sinai, Ctr Vaccine Res & Pandem Preparedness, New York, NY 10029 USA
所属机构:
Icahn Sch Med Mt SinainIcahn School of Medicine at Mount Sinai
电子邮件地址:
--
通讯地址历史:
Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA
所属机构
Icahn Sch Med Mt Sinai
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai Department of Medicine
James J Peters VA Med Ctr, Bronx, NY 10468 USA
所属机构
James J Peters VA Med Ctr
US Department of Veterans Affairs
Veterans Health Administration (VHA)
James J. Peters VA Medical Center
NYU Sch Med, Dept Environm Med, New York, NY USA
所属机构
NYU Sch Med
New York University
NYU Grossman School of Medicine
New York University Department of Medicine
New York University Division of Environmental Medicine
Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA
所属机构
Icahn Sch Med Mt Sinai
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai Department of Microbiology
Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA
所属机构
Icahn Sch Med Mt Sinai
Icahn School of Medicine at Mount Sinai
Icahn Sch Med Mt Sinai, Dept Pathol Mol & Cell Based Med, New York, NY 10029 USA
所属机构
Icahn Sch Med Mt Sinai
Icahn School of Medicine at Mount Sinai
Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA
所属机构
Icahn Sch Med Mt Sinai
Icahn School of Medicine at Mount Sinai
免责声明免责声明
1、猫眼课题宝专注于为科研工作者提供省时、高效的文献资源检索和预览服务;
2、网站中的文献信息均来自公开、合规、透明的互联网文献查询网站,可以通过页面中的“来源链接”跳转数据网站。
3、在猫眼课题宝点击“求助全文”按钮,发布文献应助需求时求助者需要支付50喵币作为应助成功后的答谢给应助者,发送到用助者账户中。若文献求助失败支付的50喵币将退还至求助者账户中。所支付的喵币仅作为答谢,而不是作为文献的“购买”费用,平台也不从中收取任何费用,
4、特别提醒用户通过求助获得的文献原文仅用户个人学习使用,不得用于商业用途,否则一切风险由用户本人承担;
5、本平台尊重知识产权,如果权利所有者认为平台内容侵犯了其合法权益,可以通过本平台提供的版权投诉渠道提出投诉。一经核实,我们将立即采取措施删除/下架/断链等措施。
我已知晓